news
HIV-positive population faces new longevity challenges
With antiretroviral therapies extending lifespans for millions with HIV, the new focus is on managing aging-related health issues. Drauzio Varella reports that this population now grapples with conditions like cardiovascular disease, diabetes, and neurocognitive disorders at higher rates. It's about ensuring quality of life, not just survival.
With antiretroviral therapies extending lifespans for millions with HIV, the new focus is on managing aging-related health issues. Drauzio Varella reports that this population now grapples with conditions like cardiovascular disease, diabetes, and neurocognitive disorders at higher rates. It's about ensuring quality of life, not just survival.
The architecture take
The story isn't just about HIV anymore; it's about what happens when a chronic condition becomes a chronic aging condition. Antiretrovirals bought decades, which is huge, but now the body's bill comes due — just for different things. Think increased inflammation, mitochondrial dysfunction, and accelerated cellular aging making themselves known as diabetes or heart disease. It means a shift from just suppressing the virus to managing a whole suite of age-related systemic issues, often earlier than the general population. This isn't just a medical problem; it's a policy and wellness challenge, too. If we can keep people alive, we need to keep them well in their later years. Watch for integrated care models that treat the whole person, not just the virus, and a stronger focus on preventive health for this group.